The 11 remaining bidders in the race for places on the £4 billion ProCure 21+ framework are working flat out towards a deadline at the end of this month.
Tenders are understood to be due in on Friday 29 January, with the Department of Health expected to select six winners in April.
A Sir Robert McAlpine/Vinci joint venture also picked up tender documents, as did Medicinq – a consortium led by Midas and recently joined by Shepherd.
The shortlist is completed by Willmott Dixon, Bovis Lend Lease, Miller, and 2VB – a consortium of Volker Fitzpatrick, Thomas Vale and Henry Boot.
Competition for places has been fierce – more than 50 contractors received pre-qualification questionnaires for the six-year health agreement, although only 18 submitted them.
One source said: “There are lots of teams out there working very hard. We have a very substantial team working on this.”
The final tender process has been described as cost and technical based, and scores from pre-qualification process do not carry through.
Another bidder told CNplus: “It will be a very tough competition.”
The DoH has stated that ProCure 21+ will vary from its predecessor, ProCure 21, by:
- Placing greater emphasis on the assurance of build standards and the sustainability of outcomes;
- Meeting the requirements of the new and changing NHS landscape;
- Enhancing framework management to improve quality. Contractors are eager to win places on the framework, which could offer an oasis of work in an arid public sector landscape over the next few years.